Alimera Sciences to Participate in Benzinga Biotech Small Cap Conference

Rhea-AI Summary

Alimera Sciences (Nasdaq: ALIM) announced that its President and CEO, Rick Eiswirth, will present at the Benzinga Biotech Small Cap Conference on March 25, 2021, at 12:00 pm ET. The conference will take place from March 24-25, 2021. Investors can view Eiswirth's presentation after registration and request a 1x1 meeting. Alimera is focused on the development of ophthalmic pharmaceuticals for retinal diseases, addressing a significant need in an aging population. For more information, visit www.alimerasciences.com.

ATLANTA, March 18, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announced today that President and CEO Rick Eiswirth will participate in the Benzinga Biotech Small Cap Conference to be held March 24-25, 2021.

Mr. Eiswirth will present on March 25 at 12:00 pm ET.

Investors can view Mr. Eiswirth’s general corporate presentation once they register for the conference here and can also request a 1x1 meeting with Mr. Eiswirth.

About Alimera Sciences, Inc.

Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.

For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com

For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com

FAQ

When will Alimera Sciences present at the Benzinga Biotech Small Cap Conference?

Alimera Sciences will present on March 25, 2021, at 12:00 pm ET.

Where can I view Alimera Sciences' CEO Rick Eiswirth's presentation?

Investors can view the presentation after registering for the Benzinga Biotech Small Cap Conference.

What is Alimera Sciences focused on?

Alimera Sciences specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for retinal diseases.

What are the dates for the Benzinga Biotech Small Cap Conference?

The conference will be held from March 24-25, 2021.

How can I request a meeting with Mr. Eiswirth during the conference?

Participants can request a 1x1 meeting with Mr. Eiswirth after registering for the conference.